Sbi Securities Co., Ltd. Ovid Therapeutics Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 84 shares of OVID stock, worth $36. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84Holding current value
$36% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding OVID
# of Institutions
82Shares Held
40.7MCall Options Held
2.4KPut Options Held
200-
Rubric Capital Management LP New York, NY5.32MShares$2.34 Million0.08% of portfolio
-
Black Rock Inc. New York, NY3.99MShares$1.76 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$1.7 Million0.13% of portfolio
-
Madison Avenue Partners, LP New York, NY3.72MShares$1.64 Million0.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.15MShares$1.39 Million0.0% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $31M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...